AT10 250micrograms/ml oral solution

দেশ: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Dihydrotachysterol

থেকে পাওয়া:

Esteve Pharmaceuticals Ltd

এটিসি কোড:

A11CC02

INN (আন্তর্জাতিক নাম):

Dihydrotachysterol

ডোজ:

250microgram/1ml

ফার্মাসিউটিকাল ফর্ম:

Oral solution

প্রশাসন রুট:

Oral

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Valid as a prescribable product

পণ্য সারাংশ:

BNF: 09060400; GTIN: 5039021506043

তথ্য লিফলেট

PATIENT INFORMATION LEAFLET
AT 10
®
250 micrograms/ml
Oral Drops, Solution
Dihydrotachysterol
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or your pharmacist.
•
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their symptoms
are the same as yours.
•
If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet, please tell your
doctor or pharmacist.
1. WHAT AT
10 IS AND WHAT IT IS USED FOR
AT 10 contains the active ingredient dihydrotachysterol, which is a
form of vitamin D. It is an oily solution used to treat
tetany (muscle spasms) due to a low blood calcium level caused by an
underactive thyroid gland.
The full name of this medicine is AT 10 250 micrograms/ml Oral Drops,
Solution. In this leaflet it is referred to as AT
10.
2. BEFORE YOU TAKE AT
10
AT 10 CONTAINS ARACHIS OIL (PEANUT OIL).
IF YOU ARE ALLERGIC TO PEANUTS OR SOYA DO NOT USE AT 10.
DO NOT TAKE AT 10 IF YOU:
• are ALLERGIC (hypersensitive) to DIHYDROTACHYSTEROL
• have HIGH BLOOD CALCIUM levels (hypercalcaemia)
• have EXCESSIVE VITAMIN D levels (hypervitaminosis D)
• are BREASTFEEDING
TAKE SPECIAL CARE WITH AT 10 IF YOU:
• suffer from SARCOIDOSIS (a condition of unknown cause, which can
be associated with high blood calcium levels)
• are PREGNANT
Tell your doctor if you believe any of the above conditions apply to
you.
Prolonged treatment with AT 10 may lead to high calcium levels
(hypercalcaemia) which may damage your kidneys. Your
doctor will monitor your blood calcium levels.
TAKING OTHER MEDICINES
You should tell your doctor if you are taking or have taken any of the
following medicines as they may interact with
AT 10:
• thyroid hormones
• cholestyramine (cholesterol lowering medicine)
• thiazide diuretics (water pills)
• barbiturates (sleeping pills)
• anticonvulsants (epilepsy medicines)
• ri

পণ্য বৈশিষ্ট্য

OBJECT 1
AT10
Summary of Product Characteristics Updated 17-Jul-2014 | Intrapharm
Laboratories Limited
1. Name of the medicinal product
AT 10.
2. Qualitative and quantitative composition
Dihydrotachysterol BP 0.025% w/v.
3. Pharmaceutical form
Oily solution.
4. Clinical particulars
4.1 Therapeutic indications
AT 10 is recommended for use in acute, chronic and latent forms of
hypocalcaemic tetany due to
hypoparathyroidism where its action is to increase the rate of
absorption and utilisation of calcium.
4.2 Posology and method of administration
_ADULTS (AND THE ELDERLY)_
In acute cases 3-5 ml may be given on each of the first three days of
treatment, followed two to three days
later by blood and urinary calcium estimations. The maintenance dose
of AT 10 is usually within the
range of 1-7 ml each week, but the precise amount depends on the
results of serum and urinary calcium
determinations. In chronic cases an initial dose of 2 ml of AT 10
daily, or on alternate days, may be
sufficient to maintain normocalcaemia in moderate cases. The dose of
AT 10 usually has to be increased
during menstruation and periods of unusual activity.
_CHILDREN_
No specific dosage recommendations.
ROUTE OF ADMINISTRATION
Oral.
4.3 Contraindications
Hypersensitivity to dihydrotachysterol
Hypercalcaemia.
Hypervitaminosis D.
Allergy to nuts (including peanuts)
4.4 Special warnings and precautions for use
AT 10 contains arachis oil (peanut oil) and should not be taken by
patients known to be allergic to peanut.
As there is a possible relationship between allergy to peanut and
allergy to soya, patients with soya
allergy should also avoid AT 10. As with calciferol, uncontrolled
prolonged administration of AT 10 can
result in hypercalcaemia which may lead to nephrocalcinosis. Therefore
accurate blood calcium
determinations must be made at the beginning of treatment and then
periodically until the required
maintenance dose has been established. The serum calcium level should
subsequently be kept between
2.25-2.5 mmol/litre. Serum phosphate, magn